Kaitai Capital
Hangzhou, Zhejiangkaitaicapital.com
Overview
Kaitai Capital, established in 2009, focuses on innovative and industrial investments across diverse sectors including biopharma, healthcare services, agriculture tech, consumer business, and digital technology . The firm's investment strategy spans various stages, from seed to Series C rounds, demonstrating flexibility in supporting companies at different growth phases .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PaXini Tech | Mar 2026 | Series B | Lead |
| Deep Intelligent Pharma | Feb 2026 | VC Round | Co-investor |
| OncoC4, Inc. | Oct 2025 | Series B | Co-investor |
| Lupeng Pharmaceutical | Sep 2025 | Series B | Co-investor |
| Suzhou Shincell New Material Co., Ltd. | Sep 2024 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
